Want to join the conversation?
$CLX 4Q15 Call: FY15: free cash flow was $733MM vs. $649MM in FY14, up 13%; highest level delivered in more than 10 years. Clorox repurchased about 4MM shares for about $434MM in FY15 and increased its dividend by 4% in 4Q15. At FY15-end, debt-to-EBITDA ratio was 1.8, below company's target of 2.0 to 2.5.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?